Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The Journal of Headache and Pain
|
November 24, 2022
Tracking the evolution of non-headache symptoms through the migraine attack
Roberta Messina, Ilaria Cetta, Bruno Colombo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
August 27, 2020
Stress in paediatric migraine: a trigger factor?
Bruno Colombo, Ilaria Cetta, Roberta Messina, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 6, 2022
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study
Ilaria Cetta, Roberta Messina, Laura Zanandrea, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 23, 2021
Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
Antonino Giordano, Ilaria Cetta, Mario Orrico, et al.
Expert Review of Neurotherapeutics
|
June 20, 2026
An update on the differential diagnosis of migraine in adults: when and how neuroimaging makes the difference
Roberta Messina, Alessandro Antoniazzi, Ilaria Cetta, et al.
Multiple Sclerosis and Related Disorders
|
November 13, 2019
Cortical M1 plasticity and metaplasticity in patients with multiple sclerosis
Viola Baione, Daniele Belvisi, Antonio Cortese, et al.
Journal of Neurology
|
October 28, 2025
Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report
Leonardo Palazzo, Ilaria Cetta, Lucia Bongiovanni, et al.
European Journal of Neurology
|
September 5, 2024
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study
Laura Zanandrea, Roberta Messina, Ilaria Cetta, et al.
European Journal of Neurology
|
May 25, 2023
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience
Simone Guerrieri, Chiara Bucca, Agostino Nozzolillo, et al.
The Journal of Headache and Pain
|
June 7, 2022
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The Journal of Headache and Pain
|
November 24, 2022
Tracking the evolution of non-headache symptoms through the migraine attack
Roberta Messina, Ilaria Cetta, Bruno Colombo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
August 27, 2020
Stress in paediatric migraine: a trigger factor?
Bruno Colombo, Ilaria Cetta, Roberta Messina, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 6, 2022
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study
Ilaria Cetta, Roberta Messina, Laura Zanandrea, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
July 23, 2021
Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
Antonino Giordano, Ilaria Cetta, Mario Orrico, et al.
Expert Review of Neurotherapeutics
|
June 20, 2026
An update on the differential diagnosis of migraine in adults: when and how neuroimaging makes the difference
Roberta Messina, Alessandro Antoniazzi, Ilaria Cetta, et al.
Multiple Sclerosis and Related Disorders
|
November 13, 2019
Cortical M1 plasticity and metaplasticity in patients with multiple sclerosis
Viola Baione, Daniele Belvisi, Antonio Cortese, et al.
Journal of Neurology
|
October 28, 2025
Clinical and neuroradiological evolution of thymoma-associated anti-GABAA receptor autoimmune encephalitis: insights from a clinical case report
Leonardo Palazzo, Ilaria Cetta, Lucia Bongiovanni, et al.
European Journal of Neurology
|
September 5, 2024
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study
Laura Zanandrea, Roberta Messina, Ilaria Cetta, et al.
European Journal of Neurology
|
May 25, 2023
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience
Simone Guerrieri, Chiara Bucca, Agostino Nozzolillo, et al.
The Journal of Headache and Pain
|
June 7, 2022
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Page
of 2